JPWO2022202785A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022202785A5 JPWO2022202785A5 JP2023509184A JP2023509184A JPWO2022202785A5 JP WO2022202785 A5 JPWO2022202785 A5 JP WO2022202785A5 JP 2023509184 A JP2023509184 A JP 2023509184A JP 2023509184 A JP2023509184 A JP 2023509184A JP WO2022202785 A5 JPWO2022202785 A5 JP WO2022202785A5
- Authority
- JP
- Japan
- Prior art keywords
- administration
- dosage
- pharmaceutical composition
- administration method
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021047225 | 2021-03-22 | ||
| PCT/JP2022/013074 WO2022202785A1 (ja) | 2021-03-22 | 2022-03-22 | ポリペプチド並びにそれを含む細胞融合剤及びがん治療用医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022202785A1 JPWO2022202785A1 (https=) | 2022-09-29 |
| JPWO2022202785A5 true JPWO2022202785A5 (https=) | 2024-12-16 |
Family
ID=83397484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023509184A Pending JPWO2022202785A1 (https=) | 2021-03-22 | 2022-03-22 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20250129122A1 (https=) |
| JP (1) | JPWO2022202785A1 (https=) |
| WO (1) | WO2022202785A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025225632A1 (ja) * | 2024-04-23 | 2025-10-30 | 美智子 甲賀 | コロナウイルス感染症の治療又は予防用医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861236B2 (en) * | 2002-05-24 | 2005-03-01 | Applied Nanosystems B.V. | Export and modification of (poly)peptides in the lantibiotic way |
| AP2081A (en) * | 2004-06-18 | 2010-01-04 | Ipf Pharmaceuticals Gmbh | Oligomeric peptides and their use for the treatment of HIV infections |
| AU2006227816B2 (en) * | 2005-03-15 | 2012-04-05 | Allergan, Inc. | Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systems |
| WO2008063663A2 (en) * | 2006-11-21 | 2008-05-29 | University Of Southern California | Poly (ethylene glycol) anti-body detection assays and kits for performing thereof |
| US20110117171A1 (en) * | 2009-11-18 | 2011-05-19 | Affinergy, Inc. | Implantable bone graft materials |
| WO2018098282A2 (en) * | 2016-11-22 | 2018-05-31 | Ohio State Innovation Foundation | Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof |
| WO2021054448A1 (ja) * | 2019-09-20 | 2021-03-25 | 美智子 甲賀 | ペプチド並びにそれを含む細胞融合剤及びがん治療用医薬組成物 |
-
2022
- 2022-03-22 WO PCT/JP2022/013074 patent/WO2022202785A1/ja not_active Ceased
- 2022-03-22 US US18/551,634 patent/US20250129122A1/en active Pending
- 2022-03-22 JP JP2023509184A patent/JPWO2022202785A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4507323A (en) | Treatment of psychosexual dysfunctions | |
| EP2799071B1 (en) | Levocetirizine and montelukast for the treatment of influenza and common cold | |
| AU2014249534B2 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| JP6196041B2 (ja) | 大うつ病を有する患者において減量療法を提供する方法 | |
| US20030105121A1 (en) | Method of preventing lipodystrophy syndrome or reversing a pre-existing syndrome in HIV-infected patients being treated with antiretroviral agents | |
| US20200101067A1 (en) | Use of levocetirizine and montelukast in the treatment of anaphylaxis | |
| CN111032158A (zh) | 用于治疗抑郁的nk-1拮抗剂组合物和方法 | |
| CN109316480A (zh) | 组合als疗法 | |
| JP2024010018A (ja) | うつ病を治療するための組成物および方法 | |
| US20090149518A1 (en) | Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis | |
| JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
| JPWO2022202785A5 (https=) | ||
| US20250319067A1 (en) | Improved Pharmacokinetics of Tryptamine Prodrugs | |
| EP0171227B1 (en) | Use of propiophenone compound | |
| CN118973574A (zh) | 异丁司特治疗新冠肺炎后遗症的用途 | |
| US20170231987A1 (en) | Levosimendan for use in the treatment of motor neuron diseases (e.g. als) | |
| US10071077B2 (en) | Use of enoximone in the treatment of atopic immune-related disorders, in pharmaceutical composition as well as in pharmaceutical preparation | |
| PT2877192T (pt) | Composições para o tratamento de fadiga relacionada com o cancro | |
| TWI289060B (en) | Pharmaceutical composition for improving the recovery of post-stroke patients | |
| Aizenberg et al. | Sildenafil for selective serotonin reuptake inhibitor-induced erectile dysfunction in elderly male depressed patients | |
| JP5380930B2 (ja) | 睡眠改善剤 | |
| IL230174A (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
| RU2611383C2 (ru) | Комбинированный препарат для устранения симптомов и лечения острых респираторных вирусных инфекций и гриппа | |
| WO2005063253A1 (ja) | アレルギー症状治療用医薬組成物 | |
| RU2498797C2 (ru) | Комбинированное средство для лечения гриппа и орви |